FDA approves new epinephrine injector from Adamis Pharmaceuticals
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
Symjepi, the new epinephrine injector made by Adamis Pharmaceuticals Corp., is a syringe prefilled with the epinephrine hormone, which is capable of stopping life-threatening allergic reactions from insect stings, foods like eggs and certain medications.
Accordiing to San Diego-based Adamis, its new product is easier to use than EpiPen that comes filled with a set dose and is accompanied by a training device.
In addition, Symjepi will be easier to carry as it is notably smaller than EpiPen. Most kids and adults with severe allergies have to carry an injector wherever they go.
Evercore ISI analyst Umer Raffat and some others have pointed out that Symjepi isn’t totally identical to EpiPen; so its price will definitely be a key consideration.
Currently, Mylan Pharmaceuticals’ EpiPen costs in the range of $630 to $700 without insurance. The new generic version retails for around $225 to $425.
A Translational Pharmaceutics stage, Quotient Clinical connoting its new personality to Quotient Sciences resulting acquirements of SeaView Research, QS Pharma, and Co-Formulate.
Intelligent and connected vehicles are turning into the Chinese business' specialty in the new automotive era. TuSimple Inc. reveals demonstrates minds-off automated driving using two modified trucks in Shanghai.
Well-known for its technology innovation, China region unveiled the first picture of the hypersonic strike airplane that is being created to convey atomic warheads through U.S. rocket protections. The pictures of four distinct rockets that U.S.
New York-based broad communications partnership, Time Inc. uncovered another advanced stage called Time Inc. Latino. Through its new computerized stage Time conveys exceptional access to the U.S. Hispanic group of viewers.
Chinese Multinational Telecommunication Equipment company, ZTE corporation officially released TECS 6.0. The company released the new generation cloud platform at the OpenStack Summit Sydney.
German-based, multinational open-source software company SUSE combines Cloud Foundry and Kubernetes to accelerate application delivery, which also helps to increase business agility.